MedTrace Logo

The Microbiome in Subfertility and Assisted Reproductive Technologies (ART)

NCT03105453 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-11-03

No results posted yet for this study

Summary

To assess the impact of the female genital microbiome on ART outcome.

Conditions

Interventions

OTHER

3 Sampling points

When entering the in-vitro fertilization/intracytoplasmatic sperm injection 4 samples will be harvested: a rectal swab, a cervical swab, a vaginal swab and an intra-uterine sample using an empty embryo catheter. After the ovarian stimulation treatment, the same patients will be sampled two more times: once at the moment of oocyte retrieval (rectal, cervical, vaginal and intra-uterine samples) and again just before the embryo transfer (at this stage, the embryo culture medium will be harvested, as well as an intra-uterine sample using the tip of an empty embryo inner catheter before the embryo transfer and a rectal sample)

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Principal Investigators

  • Christophe Blockeel, PhD · Clinical head

  • Julie Bussche, Msc · Research collaborator

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-11-02
Completion
2020-11-02

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03105453 on ClinicalTrials.gov